A Novel Inhibitor of AKT1-PDPK1 Interaction Efficiently Suppresses the Activity of AKT Pathway and Restricts Tumor Growth in Vivo

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0281
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Small Molecule Inhibitor of the Β-Catenin-Tcf4 Interaction Suppresses Colorectal Cancer Growth in Vitro and in Vivo

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

A Novel Taspine Derivative Suppresses Human Liver Tumor Growth and Invasion in Vitro and in Vivo

Oncology Letters
Cancer ResearchOncology
2013English

GSK1838705A, an IGF-1R Inhibitor, Inhibits Glioma Cell Proliferation and Suppresses Tumor Growth in Vivo

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

MP470, a Novel Receptor Tyrosine Kinase Inhibitor, in Combination With Erlotinib Inhibits the HER Family/Pi3k/Akt Pathway and Tumor Growth in Prostate Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2009English

βKlotho Suppresses Tumor Growth in Hepatocellular Carcinoma by Regulating Akt/GSK-3β/Cyclin D1 Signaling Pathway

PLoS ONE
Multidisciplinary
2013English

A Novel PEGylated Liposome-Encapsulated SANT75 Suppresses Tumor Growth Through Inhibiting Hedgehog Signaling Pathway

PLoS ONE
Multidisciplinary
2013English

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

PTPRG Suppresses Tumor Growth and Invasion via Inhibition of Akt Signaling in Nasopharyngeal Carcinoma

Oncotarget
Oncology
2015English

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy